针对CLL的MRD导向治疗:准备好进入黄金时段吗?
Joanna M Rhodes1, Carlos A Lopez2, Jacqueline C Barrientos3
1Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
新型向性药物现在是慢性淋巴细胞白血病 (CLL) 治疗的标准. 测量最小残留疾病 (MRD) 提供预后价值,但其在指导治疗中的作用需要进一步调查.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子诊断学 分子诊断
背景情况:
- 慢性淋巴细胞白血病 (CLL) 的治疗已经从化疗免疫疗法转向向药物,如布鲁顿的氨酸激酶抑制剂和venetoclax.
- 这些新疗法现在是前线和复发性CLL病例的标准.
- 不断变化的治疗环境需要对治疗终点进行重新评估.
研究的目的:
- 审查CLL中最小残留疾病 (MRD) 的定义和检测试验.
- 讨论MRD对长期生存结果的预后影响.
- 为解决关于MRD导向治疗及其临床实用性的持续辩论.
主要方法:
- 对MRD检测研究的文献综述及其在CLL中的临床意义.
- 分析数据,比较不同的MRD测定及其预后价值.
- 讨论关于MRD监测的当前临床试验数据和专家意见.
主要成果:
- 最小残留疾病 (MRD) 检测是评估CLL治疗反应的敏感方法.
- 在各种治疗方式中,MRD已经显示出显著的预后价值.
- 关于最佳MRD测定和MRD监测对治疗策略的影响的比较数据有限.
结论:
- 虽然MRD是CLL的有价值的预后标志物,但它在指导治疗中的作用仍在研究中.
- 需要进行进一步的临床试验,以建立标准化的MRD测定方法,并确定MRD引导治疗调整的好处.
- 将MRD评估纳入常规CLL管理中需要进一步验证.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K